<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Thu, 18 Jun 2026 09:00:21 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Zeiss and Envision Health partner on VR-based glaucoma testing</title>
   <link>http://www.streetinsider.com/Corporate+News/Zeiss+and+Envision+Health+partner+on+VR-based+glaucoma+testing/26663574.html</link>
   <description>

&lt;p&gt;Carl Zeiss Meditec AG (Frankfurt: AFX) announced a strategic collaboration with Envision Health Technologies to develop virtual reality-based visual function testing for glaucoma care, according to a press release issued June 18, 2026.&lt;/p&gt;

&lt;p&gt;The collaboration pairs Zeiss Medical Technology's perimetry background with Envision Health Technologies' software-driven VR platform. Envision Health Technologies was founded by Dr. Lama A. Al-Aswad, a glaucoma surgeon, who also serves as CEO of the company.&lt;/p&gt;

&lt;p&gt;The two companies said the effort is aimed at expanding patient access to glaucoma screenings and offering more flexible workflow options through portable, software-based approaches to visual field testing.&lt;/p&gt;

&lt;p&gt;&quot;As glaucoma care continues to</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Zeiss+and+Envision+Health+partner+on+VR-based+glaucoma+testing/26663574.html</guid>
   <pubDate>Thu, 18 Jun 2026 09:00:21 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03578601</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16161087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37332261</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CZMWY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00244597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01229783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15789788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22986476</category>
   	  </item>
  <item>
   <title>Zeiss and Envision Health partner on VR-based glaucoma testing</title>
   <link>http://www.streetinsider.com/Corporate+News/Zeiss+and+Envision+Health+partner+on+VR-based+glaucoma+testing/26663574.html</link>
   <description>

&lt;p&gt;Carl Zeiss Meditec AG (Frankfurt: AFX) announced a strategic collaboration with Envision Health Technologies to develop virtual reality-based visual function testing for glaucoma care, according to a press release issued June 18, 2026.&lt;/p&gt;

&lt;p&gt;The collaboration pairs Zeiss Medical Technology's perimetry background with Envision Health Technologies' software-driven VR platform. Envision Health Technologies was founded by Dr. Lama A. Al-Aswad, a glaucoma surgeon, who also serves as CEO of the company.&lt;/p&gt;

&lt;p&gt;The two companies said the effort is aimed at expanding patient access to glaucoma screenings and offering more flexible workflow options through portable, software-based approaches to visual field testing.&lt;/p&gt;

&lt;p&gt;&quot;As glaucoma care continues to</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Zeiss+and+Envision+Health+partner+on+VR-based+glaucoma+testing/26663574.html</guid>
   <pubDate>Thu, 18 Jun 2026 09:00:21 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03578601</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16161087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37332261</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CZMWY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00244597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01229783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15789788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22986476</category>
   	  </item>
  <item>
   <title>Zeiss and Envision Health partner on VR-based glaucoma testing</title>
   <link>http://www.streetinsider.com/Corporate+News/Zeiss+and+Envision+Health+partner+on+VR-based+glaucoma+testing/26663574.html</link>
   <description>

&lt;p&gt;Carl Zeiss Meditec AG (Frankfurt: AFX) announced a strategic collaboration with Envision Health Technologies to develop virtual reality-based visual function testing for glaucoma care, according to a press release issued June 18, 2026.&lt;/p&gt;

&lt;p&gt;The collaboration pairs Zeiss Medical Technology's perimetry background with Envision Health Technologies' software-driven VR platform. Envision Health Technologies was founded by Dr. Lama A. Al-Aswad, a glaucoma surgeon, who also serves as CEO of the company.&lt;/p&gt;

&lt;p&gt;The two companies said the effort is aimed at expanding patient access to glaucoma screenings and offering more flexible workflow options through portable, software-based approaches to visual field testing.&lt;/p&gt;

&lt;p&gt;&quot;As glaucoma care continues to</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Zeiss+and+Envision+Health+partner+on+VR-based+glaucoma+testing/26663574.html</guid>
   <pubDate>Thu, 18 Jun 2026 09:00:21 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03578601</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16161087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37332261</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CZMWY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00244597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01229783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15789788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22986476</category>
   	  </item>
  <item>
   <title>Zeiss and Envision Health partner on VR-based glaucoma testing</title>
   <link>http://www.streetinsider.com/Corporate+News/Zeiss+and+Envision+Health+partner+on+VR-based+glaucoma+testing/26663574.html</link>
   <description>

&lt;p&gt;Carl Zeiss Meditec AG (Frankfurt: AFX) announced a strategic collaboration with Envision Health Technologies to develop virtual reality-based visual function testing for glaucoma care, according to a press release issued June 18, 2026.&lt;/p&gt;

&lt;p&gt;The collaboration pairs Zeiss Medical Technology's perimetry background with Envision Health Technologies' software-driven VR platform. Envision Health Technologies was founded by Dr. Lama A. Al-Aswad, a glaucoma surgeon, who also serves as CEO of the company.&lt;/p&gt;

&lt;p&gt;The two companies said the effort is aimed at expanding patient access to glaucoma screenings and offering more flexible workflow options through portable, software-based approaches to visual field testing.&lt;/p&gt;

&lt;p&gt;&quot;As glaucoma care continues to</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Zeiss+and+Envision+Health+partner+on+VR-based+glaucoma+testing/26663574.html</guid>
   <pubDate>Thu, 18 Jun 2026 09:00:21 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03578601</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16161087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37332261</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CZMWY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00244597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01229783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15789788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22986476</category>
   	  </item>
  <item>
   <title>Zeiss and Envision Health partner on VR-based glaucoma testing</title>
   <link>http://www.streetinsider.com/Corporate+News/Zeiss+and+Envision+Health+partner+on+VR-based+glaucoma+testing/26663574.html</link>
   <description>

&lt;p&gt;Carl Zeiss Meditec AG (Frankfurt: AFX) announced a strategic collaboration with Envision Health Technologies to develop virtual reality-based visual function testing for glaucoma care, according to a press release issued June 18, 2026.&lt;/p&gt;

&lt;p&gt;The collaboration pairs Zeiss Medical Technology's perimetry background with Envision Health Technologies' software-driven VR platform. Envision Health Technologies was founded by Dr. Lama A. Al-Aswad, a glaucoma surgeon, who also serves as CEO of the company.&lt;/p&gt;

&lt;p&gt;The two companies said the effort is aimed at expanding patient access to glaucoma screenings and offering more flexible workflow options through portable, software-based approaches to visual field testing.&lt;/p&gt;

&lt;p&gt;&quot;As glaucoma care continues to</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Zeiss+and+Envision+Health+partner+on+VR-based+glaucoma+testing/26663574.html</guid>
   <pubDate>Thu, 18 Jun 2026 09:00:21 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03578601</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16161087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37332261</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CZMWY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00244597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01229783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15789788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22986476</category>
   	  </item>
  <item>
   <title>Zeiss and Envision Health partner on VR-based glaucoma testing</title>
   <link>http://www.streetinsider.com/Corporate+News/Zeiss+and+Envision+Health+partner+on+VR-based+glaucoma+testing/26663574.html</link>
   <description>

&lt;p&gt;Carl Zeiss Meditec AG (Frankfurt: AFX) announced a strategic collaboration with Envision Health Technologies to develop virtual reality-based visual function testing for glaucoma care, according to a press release issued June 18, 2026.&lt;/p&gt;

&lt;p&gt;The collaboration pairs Zeiss Medical Technology's perimetry background with Envision Health Technologies' software-driven VR platform. Envision Health Technologies was founded by Dr. Lama A. Al-Aswad, a glaucoma surgeon, who also serves as CEO of the company.&lt;/p&gt;

&lt;p&gt;The two companies said the effort is aimed at expanding patient access to glaucoma screenings and offering more flexible workflow options through portable, software-based approaches to visual field testing.&lt;/p&gt;

&lt;p&gt;&quot;As glaucoma care continues to</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Zeiss+and+Envision+Health+partner+on+VR-based+glaucoma+testing/26663574.html</guid>
   <pubDate>Thu, 18 Jun 2026 09:00:21 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03578601</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16161087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37332261</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CZMWY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00244597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01229783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15789788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22986476</category>
   	  </item>
  <item>
   <title>Zeiss and Envision Health partner on VR-based glaucoma testing</title>
   <link>http://www.streetinsider.com/Corporate+News/Zeiss+and+Envision+Health+partner+on+VR-based+glaucoma+testing/26663574.html</link>
   <description>

&lt;p&gt;Carl Zeiss Meditec AG (Frankfurt: AFX) announced a strategic collaboration with Envision Health Technologies to develop virtual reality-based visual function testing for glaucoma care, according to a press release issued June 18, 2026.&lt;/p&gt;

&lt;p&gt;The collaboration pairs Zeiss Medical Technology's perimetry background with Envision Health Technologies' software-driven VR platform. Envision Health Technologies was founded by Dr. Lama A. Al-Aswad, a glaucoma surgeon, who also serves as CEO of the company.&lt;/p&gt;

&lt;p&gt;The two companies said the effort is aimed at expanding patient access to glaucoma screenings and offering more flexible workflow options through portable, software-based approaches to visual field testing.&lt;/p&gt;

&lt;p&gt;&quot;As glaucoma care continues to</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Zeiss+and+Envision+Health+partner+on+VR-based+glaucoma+testing/26663574.html</guid>
   <pubDate>Thu, 18 Jun 2026 09:00:21 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03578601</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16161087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37332261</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CZMWY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00244597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01229783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15789788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22986476</category>
   	  </item>
  <item>
   <title>Zeiss and Envision Health partner on VR-based glaucoma testing</title>
   <link>http://www.streetinsider.com/Corporate+News/Zeiss+and+Envision+Health+partner+on+VR-based+glaucoma+testing/26663574.html</link>
   <description>

&lt;p&gt;Carl Zeiss Meditec AG (Frankfurt: AFX) announced a strategic collaboration with Envision Health Technologies to develop virtual reality-based visual function testing for glaucoma care, according to a press release issued June 18, 2026.&lt;/p&gt;

&lt;p&gt;The collaboration pairs Zeiss Medical Technology's perimetry background with Envision Health Technologies' software-driven VR platform. Envision Health Technologies was founded by Dr. Lama A. Al-Aswad, a glaucoma surgeon, who also serves as CEO of the company.&lt;/p&gt;

&lt;p&gt;The two companies said the effort is aimed at expanding patient access to glaucoma screenings and offering more flexible workflow options through portable, software-based approaches to visual field testing.&lt;/p&gt;

&lt;p&gt;&quot;As glaucoma care continues to</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Zeiss+and+Envision+Health+partner+on+VR-based+glaucoma+testing/26663574.html</guid>
   <pubDate>Thu, 18 Jun 2026 09:00:21 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03578601</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16161087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37332261</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CZMWY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00244597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01229783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15789788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22986476</category>
   	  </item>
  <item>
   <title>Zeiss and Envision Health partner on VR-based glaucoma testing</title>
   <link>http://www.streetinsider.com/Corporate+News/Zeiss+and+Envision+Health+partner+on+VR-based+glaucoma+testing/26663574.html</link>
   <description>

&lt;p&gt;Carl Zeiss Meditec AG (Frankfurt: AFX) announced a strategic collaboration with Envision Health Technologies to develop virtual reality-based visual function testing for glaucoma care, according to a press release issued June 18, 2026.&lt;/p&gt;

&lt;p&gt;The collaboration pairs Zeiss Medical Technology's perimetry background with Envision Health Technologies' software-driven VR platform. Envision Health Technologies was founded by Dr. Lama A. Al-Aswad, a glaucoma surgeon, who also serves as CEO of the company.&lt;/p&gt;

&lt;p&gt;The two companies said the effort is aimed at expanding patient access to glaucoma screenings and offering more flexible workflow options through portable, software-based approaches to visual field testing.&lt;/p&gt;

&lt;p&gt;&quot;As glaucoma care continues to</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Zeiss+and+Envision+Health+partner+on+VR-based+glaucoma+testing/26663574.html</guid>
   <pubDate>Thu, 18 Jun 2026 09:00:21 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03578601</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16161087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37332261</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CZMWY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00244597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01229783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15789788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22986476</category>
   	  </item>
  <item>
   <title>ZEISS announces strategic collaboration with Envision Health Technologies to advance glaucoma care with virtual reality-based function testing</title>
   <link>http://www.streetinsider.com/Press+Releases/ZEISS+announces+strategic+collaboration+with+Envision+Health+Technologies+to+advance+glaucoma+care+with+virtual+reality-based+function+testing/26663522.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;ZEISS Medical Technology and Envision Health Technologies will collaborate to advance the next generation of patient-accessible, software-driven visual function testing while maintaining a science-first approach to glaucoma care.&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;JENA, &lt;location value=&quot;LC/de&quot; idsrc=&quot;xmltag.org&quot; &gt;Germany&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 18, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- ZEISS Medical Technology, one of the world's leading medical technology companies, today announced a strategic collaboration with Envision Health Technologies, a leading digital eye health company founded by renowned glaucoma surgeon Dr. &lt;person&gt;Lama A. Al-Aswad&lt;/person&gt;, to help advance glaucoma care through gamified virtual reality (VR) technology. The collaboration aims to firmly strengthen scientific and clinical credibility in VR-based visual function</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/ZEISS+announces+strategic+collaboration+with+Envision+Health+Technologies+to+advance+glaucoma+care+with+virtual+reality-based+function+testing/26663522.html</guid>
   <pubDate>Thu, 18 Jun 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03578601</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16161087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37332261</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CZMWY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00244597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01229783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15789788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22986476</category>
   	  </item>
  <item>
   <title>ZEISS announces strategic collaboration with Envision Health Technologies to advance glaucoma care with virtual reality-based function testing</title>
   <link>http://www.streetinsider.com/Press+Releases/ZEISS+announces+strategic+collaboration+with+Envision+Health+Technologies+to+advance+glaucoma+care+with+virtual+reality-based+function+testing/26663522.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;ZEISS Medical Technology and Envision Health Technologies will collaborate to advance the next generation of patient-accessible, software-driven visual function testing while maintaining a science-first approach to glaucoma care.&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;JENA, &lt;location value=&quot;LC/de&quot; idsrc=&quot;xmltag.org&quot; &gt;Germany&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 18, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- ZEISS Medical Technology, one of the world's leading medical technology companies, today announced a strategic collaboration with Envision Health Technologies, a leading digital eye health company founded by renowned glaucoma surgeon Dr. &lt;person&gt;Lama A. Al-Aswad&lt;/person&gt;, to help advance glaucoma care through gamified virtual reality (VR) technology. The collaboration aims to firmly strengthen scientific and clinical credibility in VR-based visual function</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/ZEISS+announces+strategic+collaboration+with+Envision+Health+Technologies+to+advance+glaucoma+care+with+virtual+reality-based+function+testing/26663522.html</guid>
   <pubDate>Thu, 18 Jun 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03578601</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16161087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37332261</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CZMWY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00244597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01229783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15789788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22986476</category>
   	  </item>
  <item>
   <title>ZEISS announces strategic collaboration with Envision Health Technologies to advance glaucoma care with virtual reality-based function testing</title>
   <link>http://www.streetinsider.com/Press+Releases/ZEISS+announces+strategic+collaboration+with+Envision+Health+Technologies+to+advance+glaucoma+care+with+virtual+reality-based+function+testing/26663522.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;ZEISS Medical Technology and Envision Health Technologies will collaborate to advance the next generation of patient-accessible, software-driven visual function testing while maintaining a science-first approach to glaucoma care.&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;JENA, &lt;location value=&quot;LC/de&quot; idsrc=&quot;xmltag.org&quot; &gt;Germany&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 18, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- ZEISS Medical Technology, one of the world's leading medical technology companies, today announced a strategic collaboration with Envision Health Technologies, a leading digital eye health company founded by renowned glaucoma surgeon Dr. &lt;person&gt;Lama A. Al-Aswad&lt;/person&gt;, to help advance glaucoma care through gamified virtual reality (VR) technology. The collaboration aims to firmly strengthen scientific and clinical credibility in VR-based visual function</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/ZEISS+announces+strategic+collaboration+with+Envision+Health+Technologies+to+advance+glaucoma+care+with+virtual+reality-based+function+testing/26663522.html</guid>
   <pubDate>Thu, 18 Jun 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03578601</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16161087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37332261</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CZMWY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00244597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01229783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15789788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22986476</category>
   	  </item>
  <item>
   <title>ZEISS announces strategic collaboration with Envision Health Technologies to advance glaucoma care with virtual reality-based function testing</title>
   <link>http://www.streetinsider.com/Press+Releases/ZEISS+announces+strategic+collaboration+with+Envision+Health+Technologies+to+advance+glaucoma+care+with+virtual+reality-based+function+testing/26663522.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;ZEISS Medical Technology and Envision Health Technologies will collaborate to advance the next generation of patient-accessible, software-driven visual function testing while maintaining a science-first approach to glaucoma care.&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;JENA, &lt;location value=&quot;LC/de&quot; idsrc=&quot;xmltag.org&quot; &gt;Germany&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 18, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- ZEISS Medical Technology, one of the world's leading medical technology companies, today announced a strategic collaboration with Envision Health Technologies, a leading digital eye health company founded by renowned glaucoma surgeon Dr. &lt;person&gt;Lama A. Al-Aswad&lt;/person&gt;, to help advance glaucoma care through gamified virtual reality (VR) technology. The collaboration aims to firmly strengthen scientific and clinical credibility in VR-based visual function</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/ZEISS+announces+strategic+collaboration+with+Envision+Health+Technologies+to+advance+glaucoma+care+with+virtual+reality-based+function+testing/26663522.html</guid>
   <pubDate>Thu, 18 Jun 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03578601</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16161087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37332261</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CZMWY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00244597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01229783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15789788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22986476</category>
   	  </item>
  <item>
   <title>ZEISS announces strategic collaboration with Envision Health Technologies to advance glaucoma care with virtual reality-based function testing</title>
   <link>http://www.streetinsider.com/Press+Releases/ZEISS+announces+strategic+collaboration+with+Envision+Health+Technologies+to+advance+glaucoma+care+with+virtual+reality-based+function+testing/26663522.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;ZEISS Medical Technology and Envision Health Technologies will collaborate to advance the next generation of patient-accessible, software-driven visual function testing while maintaining a science-first approach to glaucoma care.&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;JENA, &lt;location value=&quot;LC/de&quot; idsrc=&quot;xmltag.org&quot; &gt;Germany&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 18, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- ZEISS Medical Technology, one of the world's leading medical technology companies, today announced a strategic collaboration with Envision Health Technologies, a leading digital eye health company founded by renowned glaucoma surgeon Dr. &lt;person&gt;Lama A. Al-Aswad&lt;/person&gt;, to help advance glaucoma care through gamified virtual reality (VR) technology. The collaboration aims to firmly strengthen scientific and clinical credibility in VR-based visual function</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/ZEISS+announces+strategic+collaboration+with+Envision+Health+Technologies+to+advance+glaucoma+care+with+virtual+reality-based+function+testing/26663522.html</guid>
   <pubDate>Thu, 18 Jun 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03578601</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16161087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37332261</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CZMWY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00244597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01229783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15789788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22986476</category>
   	  </item>
  <item>
   <title>ZEISS announces strategic collaboration with Envision Health Technologies to advance glaucoma care with virtual reality-based function testing</title>
   <link>http://www.streetinsider.com/Press+Releases/ZEISS+announces+strategic+collaboration+with+Envision+Health+Technologies+to+advance+glaucoma+care+with+virtual+reality-based+function+testing/26663522.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;ZEISS Medical Technology and Envision Health Technologies will collaborate to advance the next generation of patient-accessible, software-driven visual function testing while maintaining a science-first approach to glaucoma care.&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;JENA, &lt;location value=&quot;LC/de&quot; idsrc=&quot;xmltag.org&quot; &gt;Germany&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 18, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- ZEISS Medical Technology, one of the world's leading medical technology companies, today announced a strategic collaboration with Envision Health Technologies, a leading digital eye health company founded by renowned glaucoma surgeon Dr. &lt;person&gt;Lama A. Al-Aswad&lt;/person&gt;, to help advance glaucoma care through gamified virtual reality (VR) technology. The collaboration aims to firmly strengthen scientific and clinical credibility in VR-based visual function</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/ZEISS+announces+strategic+collaboration+with+Envision+Health+Technologies+to+advance+glaucoma+care+with+virtual+reality-based+function+testing/26663522.html</guid>
   <pubDate>Thu, 18 Jun 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03578601</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16161087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37332261</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CZMWY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00244597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01229783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15789788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22986476</category>
   	  </item>
  <item>
   <title>ZEISS announces strategic collaboration with Envision Health Technologies to advance glaucoma care with virtual reality-based function testing</title>
   <link>http://www.streetinsider.com/Press+Releases/ZEISS+announces+strategic+collaboration+with+Envision+Health+Technologies+to+advance+glaucoma+care+with+virtual+reality-based+function+testing/26663522.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;ZEISS Medical Technology and Envision Health Technologies will collaborate to advance the next generation of patient-accessible, software-driven visual function testing while maintaining a science-first approach to glaucoma care.&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;JENA, &lt;location value=&quot;LC/de&quot; idsrc=&quot;xmltag.org&quot; &gt;Germany&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 18, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- ZEISS Medical Technology, one of the world's leading medical technology companies, today announced a strategic collaboration with Envision Health Technologies, a leading digital eye health company founded by renowned glaucoma surgeon Dr. &lt;person&gt;Lama A. Al-Aswad&lt;/person&gt;, to help advance glaucoma care through gamified virtual reality (VR) technology. The collaboration aims to firmly strengthen scientific and clinical credibility in VR-based visual function</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/ZEISS+announces+strategic+collaboration+with+Envision+Health+Technologies+to+advance+glaucoma+care+with+virtual+reality-based+function+testing/26663522.html</guid>
   <pubDate>Thu, 18 Jun 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03578601</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16161087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37332261</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CZMWY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00244597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01229783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15789788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22986476</category>
   	  </item>
  <item>
   <title>ZEISS announces strategic collaboration with Envision Health Technologies to advance glaucoma care with virtual reality-based function testing</title>
   <link>http://www.streetinsider.com/Press+Releases/ZEISS+announces+strategic+collaboration+with+Envision+Health+Technologies+to+advance+glaucoma+care+with+virtual+reality-based+function+testing/26663522.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;ZEISS Medical Technology and Envision Health Technologies will collaborate to advance the next generation of patient-accessible, software-driven visual function testing while maintaining a science-first approach to glaucoma care.&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;JENA, &lt;location value=&quot;LC/de&quot; idsrc=&quot;xmltag.org&quot; &gt;Germany&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 18, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- ZEISS Medical Technology, one of the world's leading medical technology companies, today announced a strategic collaboration with Envision Health Technologies, a leading digital eye health company founded by renowned glaucoma surgeon Dr. &lt;person&gt;Lama A. Al-Aswad&lt;/person&gt;, to help advance glaucoma care through gamified virtual reality (VR) technology. The collaboration aims to firmly strengthen scientific and clinical credibility in VR-based visual function</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/ZEISS+announces+strategic+collaboration+with+Envision+Health+Technologies+to+advance+glaucoma+care+with+virtual+reality-based+function+testing/26663522.html</guid>
   <pubDate>Thu, 18 Jun 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03578601</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16161087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37332261</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CZMWY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00244597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01229783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15789788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22986476</category>
   	  </item>
  <item>
   <title>ZEISS announces strategic collaboration with Envision Health Technologies to advance glaucoma care with virtual reality-based function testing</title>
   <link>http://www.streetinsider.com/Press+Releases/ZEISS+announces+strategic+collaboration+with+Envision+Health+Technologies+to+advance+glaucoma+care+with+virtual+reality-based+function+testing/26663522.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;ZEISS Medical Technology and Envision Health Technologies will collaborate to advance the next generation of patient-accessible, software-driven visual function testing while maintaining a science-first approach to glaucoma care.&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;JENA, &lt;location value=&quot;LC/de&quot; idsrc=&quot;xmltag.org&quot; &gt;Germany&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 18, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- ZEISS Medical Technology, one of the world's leading medical technology companies, today announced a strategic collaboration with Envision Health Technologies, a leading digital eye health company founded by renowned glaucoma surgeon Dr. &lt;person&gt;Lama A. Al-Aswad&lt;/person&gt;, to help advance glaucoma care through gamified virtual reality (VR) technology. The collaboration aims to firmly strengthen scientific and clinical credibility in VR-based visual function</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/ZEISS+announces+strategic+collaboration+with+Envision+Health+Technologies+to+advance+glaucoma+care+with+virtual+reality-based+function+testing/26663522.html</guid>
   <pubDate>Thu, 18 Jun 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03578601</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16161087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37332261</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CZMWY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00244597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01229783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15789788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22986476</category>
   	  </item>
  <item>
   <title>ZEISS announces strategic collaboration with Envision Health Technologies to advance glaucoma care with virtual reality-based function testing</title>
   <link>http://www.streetinsider.com/PRNewswire/ZEISS+announces+strategic+collaboration+with+Envision+Health+Technologies+to+advance+glaucoma+care+with+virtual+reality-based+function+testing/26663522.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;ZEISS Medical Technology and Envision Health Technologies will collaborate to advance the next generation of patient-accessible, software-driven visual function testing while maintaining a science-first approach to glaucoma care.&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;JENA, &lt;location value=&quot;LC/de&quot; idsrc=&quot;xmltag.org&quot; &gt;Germany&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 18, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- ZEISS Medical Technology, one of the world's leading medical technology companies, today announced a strategic collaboration with Envision Health Technologies, a leading digital eye health company founded by renowned glaucoma surgeon Dr. &lt;person&gt;Lama A. Al-Aswad&lt;/person&gt;, to help advance glaucoma care through gamified virtual reality (VR) technology. The collaboration aims to firmly strengthen scientific and clinical credibility in VR-based visual function</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/ZEISS+announces+strategic+collaboration+with+Envision+Health+Technologies+to+advance+glaucoma+care+with+virtual+reality-based+function+testing/26663522.html</guid>
   <pubDate>Thu, 18 Jun 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03578601</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16161087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37332261</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CZMWY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00244597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01229783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15789788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22986476</category>
   	  </item>
  <item>
   <title>ZEISS announces strategic collaboration with Envision Health Technologies to advance glaucoma care with virtual reality-based function testing</title>
   <link>http://www.streetinsider.com/PRNewswire/ZEISS+announces+strategic+collaboration+with+Envision+Health+Technologies+to+advance+glaucoma+care+with+virtual+reality-based+function+testing/26663522.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;ZEISS Medical Technology and Envision Health Technologies will collaborate to advance the next generation of patient-accessible, software-driven visual function testing while maintaining a science-first approach to glaucoma care.&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;JENA, &lt;location value=&quot;LC/de&quot; idsrc=&quot;xmltag.org&quot; &gt;Germany&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 18, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- ZEISS Medical Technology, one of the world's leading medical technology companies, today announced a strategic collaboration with Envision Health Technologies, a leading digital eye health company founded by renowned glaucoma surgeon Dr. &lt;person&gt;Lama A. Al-Aswad&lt;/person&gt;, to help advance glaucoma care through gamified virtual reality (VR) technology. The collaboration aims to firmly strengthen scientific and clinical credibility in VR-based visual function</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/ZEISS+announces+strategic+collaboration+with+Envision+Health+Technologies+to+advance+glaucoma+care+with+virtual+reality-based+function+testing/26663522.html</guid>
   <pubDate>Thu, 18 Jun 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03578601</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16161087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37332261</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CZMWY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00244597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01229783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15789788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22986476</category>
   	  </item>
  <item>
   <title>ZEISS announces strategic collaboration with Envision Health Technologies to advance glaucoma care with virtual reality-based function testing</title>
   <link>http://www.streetinsider.com/PRNewswire/ZEISS+announces+strategic+collaboration+with+Envision+Health+Technologies+to+advance+glaucoma+care+with+virtual+reality-based+function+testing/26663522.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;ZEISS Medical Technology and Envision Health Technologies will collaborate to advance the next generation of patient-accessible, software-driven visual function testing while maintaining a science-first approach to glaucoma care.&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;JENA, &lt;location value=&quot;LC/de&quot; idsrc=&quot;xmltag.org&quot; &gt;Germany&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 18, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- ZEISS Medical Technology, one of the world's leading medical technology companies, today announced a strategic collaboration with Envision Health Technologies, a leading digital eye health company founded by renowned glaucoma surgeon Dr. &lt;person&gt;Lama A. Al-Aswad&lt;/person&gt;, to help advance glaucoma care through gamified virtual reality (VR) technology. The collaboration aims to firmly strengthen scientific and clinical credibility in VR-based visual function</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/ZEISS+announces+strategic+collaboration+with+Envision+Health+Technologies+to+advance+glaucoma+care+with+virtual+reality-based+function+testing/26663522.html</guid>
   <pubDate>Thu, 18 Jun 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03578601</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16161087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37332261</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CZMWY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00244597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01229783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15789788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22986476</category>
   	  </item>
  <item>
   <title>ZEISS announces strategic collaboration with Envision Health Technologies to advance glaucoma care with virtual reality-based function testing</title>
   <link>http://www.streetinsider.com/PRNewswire/ZEISS+announces+strategic+collaboration+with+Envision+Health+Technologies+to+advance+glaucoma+care+with+virtual+reality-based+function+testing/26663522.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;ZEISS Medical Technology and Envision Health Technologies will collaborate to advance the next generation of patient-accessible, software-driven visual function testing while maintaining a science-first approach to glaucoma care.&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;JENA, &lt;location value=&quot;LC/de&quot; idsrc=&quot;xmltag.org&quot; &gt;Germany&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 18, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- ZEISS Medical Technology, one of the world's leading medical technology companies, today announced a strategic collaboration with Envision Health Technologies, a leading digital eye health company founded by renowned glaucoma surgeon Dr. &lt;person&gt;Lama A. Al-Aswad&lt;/person&gt;, to help advance glaucoma care through gamified virtual reality (VR) technology. The collaboration aims to firmly strengthen scientific and clinical credibility in VR-based visual function</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/ZEISS+announces+strategic+collaboration+with+Envision+Health+Technologies+to+advance+glaucoma+care+with+virtual+reality-based+function+testing/26663522.html</guid>
   <pubDate>Thu, 18 Jun 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03578601</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16161087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37332261</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CZMWY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00244597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01229783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15789788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22986476</category>
   	  </item>
  <item>
   <title>ZEISS announces strategic collaboration with Envision Health Technologies to advance glaucoma care with virtual reality-based function testing</title>
   <link>http://www.streetinsider.com/PRNewswire/ZEISS+announces+strategic+collaboration+with+Envision+Health+Technologies+to+advance+glaucoma+care+with+virtual+reality-based+function+testing/26663522.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;ZEISS Medical Technology and Envision Health Technologies will collaborate to advance the next generation of patient-accessible, software-driven visual function testing while maintaining a science-first approach to glaucoma care.&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;JENA, &lt;location value=&quot;LC/de&quot; idsrc=&quot;xmltag.org&quot; &gt;Germany&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 18, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- ZEISS Medical Technology, one of the world's leading medical technology companies, today announced a strategic collaboration with Envision Health Technologies, a leading digital eye health company founded by renowned glaucoma surgeon Dr. &lt;person&gt;Lama A. Al-Aswad&lt;/person&gt;, to help advance glaucoma care through gamified virtual reality (VR) technology. The collaboration aims to firmly strengthen scientific and clinical credibility in VR-based visual function</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/ZEISS+announces+strategic+collaboration+with+Envision+Health+Technologies+to+advance+glaucoma+care+with+virtual+reality-based+function+testing/26663522.html</guid>
   <pubDate>Thu, 18 Jun 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03578601</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16161087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37332261</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CZMWY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00244597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01229783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15789788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22986476</category>
   	  </item>
  <item>
   <title>ZEISS announces strategic collaboration with Envision Health Technologies to advance glaucoma care with virtual reality-based function testing</title>
   <link>http://www.streetinsider.com/PRNewswire/ZEISS+announces+strategic+collaboration+with+Envision+Health+Technologies+to+advance+glaucoma+care+with+virtual+reality-based+function+testing/26663522.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;ZEISS Medical Technology and Envision Health Technologies will collaborate to advance the next generation of patient-accessible, software-driven visual function testing while maintaining a science-first approach to glaucoma care.&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;JENA, &lt;location value=&quot;LC/de&quot; idsrc=&quot;xmltag.org&quot; &gt;Germany&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 18, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- ZEISS Medical Technology, one of the world's leading medical technology companies, today announced a strategic collaboration with Envision Health Technologies, a leading digital eye health company founded by renowned glaucoma surgeon Dr. &lt;person&gt;Lama A. Al-Aswad&lt;/person&gt;, to help advance glaucoma care through gamified virtual reality (VR) technology. The collaboration aims to firmly strengthen scientific and clinical credibility in VR-based visual function</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/ZEISS+announces+strategic+collaboration+with+Envision+Health+Technologies+to+advance+glaucoma+care+with+virtual+reality-based+function+testing/26663522.html</guid>
   <pubDate>Thu, 18 Jun 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03578601</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16161087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37332261</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CZMWY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00244597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01229783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15789788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22986476</category>
   	  </item>
  <item>
   <title>ZEISS announces strategic collaboration with Envision Health Technologies to advance glaucoma care with virtual reality-based function testing</title>
   <link>http://www.streetinsider.com/PRNewswire/ZEISS+announces+strategic+collaboration+with+Envision+Health+Technologies+to+advance+glaucoma+care+with+virtual+reality-based+function+testing/26663522.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;ZEISS Medical Technology and Envision Health Technologies will collaborate to advance the next generation of patient-accessible, software-driven visual function testing while maintaining a science-first approach to glaucoma care.&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;JENA, &lt;location value=&quot;LC/de&quot; idsrc=&quot;xmltag.org&quot; &gt;Germany&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;June 18, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- ZEISS Medical Technology, one of the world's leading medical technology companies, today announced a strategic collaboration with Envision Health Technologies, a leading digital eye health company founded by renowned glaucoma surgeon Dr. &lt;person&gt;Lama A. Al-Aswad&lt;/person&gt;, to help advance glaucoma care through gamified virtual reality (VR) technology. The collaboration aims to firmly strengthen scientific and clinical credibility in VR-based visual function</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/ZEISS+announces+strategic+collaboration+with+Envision+Health+Technologies+to+advance+glaucoma+care+with+virtual+reality-based+function+testing/26663522.html</guid>
   <pubDate>Thu, 18 Jun 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.03578601</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.16161087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37332261</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AFX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CZMWY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00244597</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01229783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.15789788</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.22986476</category>
   	  </item>
 </channel>
</rss>
